We are live on
!
Find out more
DM
Deerfield Management Portfolio holdings
AUM
$8.48B
1-Year Est. Return
99.04%
This Fund
S&P 500
This Quarter
Est. Return
+4.69%
1 Year Est. Return
+99.04%
3 Year Est. Return
+273.78%
5 Year Est. Return
+280.99%
10 Year Est. Return
+2,168.14%
AUM
$2.12B
AUM Growth
–
Cap. Flow
+$1.66B
Cap. Flow
% of AUM
78.16%
Top 10 Holdings %
Top 10 Hldgs %
29.11%
Holding
114
New
97
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AUXL
AUXILIUM PHARAMCEUTICALS INC
AUXL
|
+$77.5M |
| 2 |
INFI
Infinity Pharmaceuticals, Inc.
INFI
|
+$72.9M |
| 3 |
ARRY
Array Biopharma Inc
ARRY
|
+$58.5M |
| 4 |
Pfizer
PFE
|
+$54M |
| 5 |
NXTM
NxStage Medical Inc.
NXTM
|
+$49.2M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 50.73% |
| 2 | Technology | 1.58% |
| 3 | Financials | 1.05% |
| 4 | Energy | 0.02% |
| 5 | Consumer Discretionary | 0.01% |
Similar funds
FT
GRQ
AV
PCM
VA
QC
IC
NW
Deerfield Management's Q2 2013 Portfolio in Review
Q2 2013 is the first quarter with a 13F filing on record for Deerfield Management, which disclosed 114 positions worth $2.12B. Its ten largest holdings account for 29% of the portfolio.
Its largest position is AUXILIUM PHARAMCEUTICALS INC: 4,850,644 shares worth $80.7M.
By sector, the portfolio is most concentrated in Healthcare at 51% of assets, followed by Technology and Financials.
- Deerfield Management's largest Q2 2013 buy was AUXILIUM PHARAMCEUTICALS INC: 4,850,644 shares worth $80.7M.
- Deerfield Management's ten largest holdings make up 29% of its $2.12B portfolio in Q2 2013.
- Deerfield Management disclosed 114 positions in Q2 2013, its first 13F filing on record.
Based on Deerfield Management's 13F filing for Q2 2013, filed 14 Aug 2013.